Thank you, Madam Chair.
In our discussions about CEPA, one of the concerns is that CEPA takes a long time to actually finalize restrictions on a product. When we have consumer products and there's exposure to people who are vulnerable, CEPA simply isn't fast enough. We need something that can be used more quickly, so that's part of the rationale for this amendment.
Is there a way to address the concerns Dr. Carrie has about lack of clarity in paragraph 7(a) here, while maintaining the intent of this amendment and the benefits of a quicker response than we get through CEPA, which is frustrating to the public and also departments in government, I understand?